Important differences in management policies for children with end-stage renal disease in the Netherlands and Belgium—report from the RICH-Q study

Tromp, Wilma F.; Schoenmaker, Nikki J.; van der Lee, Johanna H.; Adams, Brigitte; Bouts, Antonia H. M.; Collard, Laure; Cransberg, Karlien; Van Damme-Lombaerts, Rita; Godefroid, Nathalie; van Hoeck, Koenraad; Koster-Kamphuis, Linda; Lilien, Marc R.; Raes, Ann; Offringa, Martin; Groothoff, Jaap W.
May 2012
Nephrology Dialysis Transplantation;May2012, Vol. 27 Issue 5, p1984
Academic Journal
Background. The low prevalence of childhood end-stage renal disease and the small centre sizes have been a barrier for clinical studies and the development of evidence-based guidelines for chronic renal replacement therapy (cRRT) in children. Few data exist on the quality of care for these patients and the applicability of existing guidelines. The aim of this study is to quantify variation in treatment policies and actually delivered care in nine centres that deliver cRRT for children. Methods. We surveyed treatment policies in all nine centres in the Netherlands and Belgium and compared them with the actually provided therapies and with recommendations from available guidelines. Data on treatment policies were gathered by questionnaires; actually provided care and outcomes were registered prospectively from 2007 to 2010. Results. Data on policies and actual patient care were obtained from all nine centres. We found relevant differences between centres in treatment policies on various topics, e.g. estimated glomerular filtration rate threshold as an indication for initiation of cRRT, preferred initial mode of cRRT, peritoneal dialysis catheter care, haemodialysis frequency and vascular access. Discrepancies were seen between stated treatment policies and actual performed therapies. For the majority of policies, no evidence-based guidelines are available. Conclusions. Health care disparities exist due to large and unwanted variation in treatment policies between hospitals providing cRRT for children. Delivered care does not live up to stated policies, for which clear and internationally accepted guidelines are lacking.


Related Articles

  • Immunization in children with chronic renal failure. Laube, Guido F.; Berger, Christoph; Goetschel, Philippe; Leumann, Ernst; Neuhaus, Thomas J. // Pediatric Nephrology;Aug2002, Vol. 17 Issue 8, p638 

    Infections jeopardize children on immunosuppression after organ transplantation. Immunization is protective in healthy children. The aims of this study were to analyze the rate and efficacy of immunization in 62 children undergoing dialysis and renal transplantation (RTPL) between 1987 and 2000....

  • Permanent hemodialysis vascular access survival in children and adolescents with end-stage renal disease. Sheth, Rita D.; Brandt, Mary L.; Brewer, Eileen D.; Nuchtern, Jed G.; Kale, Arundhati S.; Goldstein, Stuart L. // Kidney International;Nov2002, Vol. 62 Issue 5, p1864 

    Background. Transplantation is the optimal therapy for pediatric end-stage renal disease (ESRD) patients, but in a subset of patients with peritoneal membrane failure, failed transplants or poor social situations, chronic hemodialysis (HD) remains the only option. Long-term survival of...

  • Cardiac function and structure in patients with chronic renal failure. Schärer, K.; Schmidt, K. G.; Soergel, M. // Pediatric Nephrology;1999, Vol. 13 Issue 9, p951 

    The long-term consequences of cardiac alterations in children with chronic renal failure (CRF) and after renal transplantation (TX) are largely unknown. Studies in adults with end-stage renal disease (ESRD) assume that the fate of many pediatric patients is determined by a high cardiovascular...

  • Gastroduodenal lesions and Helicobacter pylori in children with end-stage renal disease. Emir, Suna; Bereket, Gamze; Boyacıoğlu, Sedat; Varan, Birgül; Tunali, Hülya; Haberal, Mehmet // Pediatric Nephrology;Aug2000, Vol. 14 Issue 8/9, p837 

    Thirty-seven children with end-stage renal disease were evaluated for gastroduodenal lesions by upper gastrointestinal endoscopy between January 1993 and January 1998. The mean (±SD) age of the patients was 14.3±2.4 years (range 9–17 years). Endoscopic examination was abnormal in 17...

  • 25 years of live related renal transplantation in children: The Buenos Aires experience. Ruiz, Eduardo; Ferraris, Jorge // Indian Journal of Urology;Oct-Dec2007, Vol. 23 Issue 4, p443 

    The number of pediatric patients with end stage renal disease (ESRD) has been steadily growing during the last 10 years all over the world, because of the improvement of medical and surgical treatment of severe urologic malformations and congenital and acquired nephrological disorders. Kidney...

  • Chronic renal insufficiency in children and adolescents: the 1996 annual report of NAPRTCS. Fivush, Barbara A.; Jabs, Kathy; Neu, Alicia M.; Kenneth Sullivan, E.; Feld, Leonard; Kohaut, Edward; Fine, Richard // Pediatric Nephrology;1998, Vol. 12 Issue 4, p328 

    The 1996 annual report of the Chronic Renal Insufficiency Arm of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) summarizes descriptive data and highlights important features on 1,725 patients from 130 centers. This database contains information on patients with an...

  • Bone mineral density in children after renal transplantation. Feber, J.; Cochat, P.; Braillon, P. // Pediatric Nephrology;Jul2000, Vol. 14 Issue 7, p654 

    A successful kidney transplantation (Tx) offers good quality of life for children suffering from chronic renal failure. However, some metabolic abnormalities may not be corrected and may persist after Tx despite good graft function. Post-Tx bone disease seems to be a universal finding in adult...

  • Outcome of reaching end stage renal failure in children under 2 years of age. Coulthard, M.G.; Crosier, J. // Archives of Disease in Childhood;Dec2002, Vol. 87 Issue 6, p511 

    Determines the outcome of children who reach end stage renal failure before the age of 2 years. Outcomes of dialysis and transplantation operations on the children; Mortality rates and effects of age at starting treatment; Implications on acute pediatrics.

  • Post graft development of short children treated with growth hormone before kidney graft. Simon, D.; Rosilio, Myriam; Maisin, Anne; Remesy, Michel; Baudouin, Véronique; Loirat, Chantal; Czernichow, Paul // Pediatric Nephrology;1999, Vol. 13 Issue 9, p723 

    Sixteen prepubertal patients with chronic renal failure (CRF) were given daily recombinant human growth hormone (rhGH) treatment (1.2 IU/kg per week) for 2.6±1.6 years until kidney transplant. Therapy was then discontinued and the patients followed for a further 3.5±1.4 years. During...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics